MedTrace Logo

Remote Neurobased Approach to Aphasia Therapy

NCT05274360 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-03-10

No results posted yet for this study

Summary

The purpose of this study is the development and validation of an evidence-based mobile application, based on the core premises of Intensive Language-Action Therapy (ILAT) for aphasia, for the training and improvement of chronic aphasia patients administered at the patient's home. It aims at testing the beneficial effect on the linguistic performance (as assessed by the Barcelona and CAL clinical tests) counteracting learned non-use and the usability of the application as a tool for training once discharged from hospital care.

Conditions

  • Aphasia, Broca
  • Aphasia, Wernicke
  • Aphasia, Fluent
  • Aphasia, Nonfluent
  • Aphasia

Interventions

BEHAVIORAL

Mobile evidence-based aphasia therapy

Use of mobile application to practice language for 2 weeks with a recommendation of 2 sessions per day of 20 minutes. The Android application, which is a Unity-based 2D game, will be installed on the patient's own phone, and they will play individually with the support of a family member if needed. The patients are free to start and stop using the application at any time. The application is safe to use, and it consists of therapeutic training methods such as object-matching, word search, writing, and manual voice recordings.

BEHAVIORAL

Conventional aphasia rehabilitation

Control Group (conventional aphasia rehabilitation). No therapy as patients are in the chronic stage, where they do not receive healthcare rehabilitation training.

Sponsors & Collaborators

  • Hospital Universitari Joan XXIII de Tarragona.

    collaborator OTHER

  • Universitat Pompeu Fabra

    collaborator OTHER

  • Institute for Bioengineering of Catalonia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-29
Primary Completion
2021-12-16
Completion
2021-12-29

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05274360 on ClinicalTrials.gov